By American Society for Colposcopy and Cervical Pathology Inc
New 2019 ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors provide new recommendations. ASCCP is pleased to offer this app to streamline navigation of the ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. The guidelines articles, as published in the Journal of Lower Genital Tract Disease, as well as the comprehensive risk estimates, can be accessed through https://www.asccp.org/guidelines. These evidence-based management guidelines, initially developed in 2019, came together through a consensus process of 19 organizations. The updated management guidelines aim to: • Allow for a more complete and precise estimation of risk • Provide more appropriate intervention for high-risk individuals (detect and treat more precancer) • Recommend less intervention for low-risk individuals (decrease testing and treatment that won’t prevent cancer and may cause reproductive harm) • Allow for the future addition of new risk modifiers and screening and management technologies See https://www.asccp.org/UserGuide for tips on using the app.
This new app isn’t as user friendly or clear as the first. Better than nothing though.
This simply does not come the may s as centroid we see patients in. Half the time it is not helpful on making a course of action. Not user friendly
Fairly difficult to navigate this app. Still nice to have the info.
Not useful Not user friendly After multiple attempts to insert the same data 3 x The result read: No recommendations Would not purchase Wish I could get my $9.99 back
This set of guidelines and this application are likely the worst I have ever seen as a physician. In no way do these guidelines help us and it is hard to imagine that they improve care for our patients. The application is almost as bad as they the guidelines. I am unbelievably saddened by the loss of efficiency and stress these guidelines will cause
Worse than the old app. Less intuitive
I hope I am missing something. I wish this app was as integrated as the previous one- this one seems to require a person have both this app for the latest guidelines, and the previous one to have the actual recommendations. Which makes sense from a monetary stand point since the last app was not updated and instead a new app was made- but frustrating from a clinician POV.
In practice for 22 years and ASCCP member for longer...disappointed to pay this fee and find missing in the app the scenario of hpv negative with lack of adequate endocervical cells.
Ap is not as helpful as last version but prob related to the guidelines being harder to navigate
Not user friendly and difficult to insert scenarios eg 30 yo with 2 neg pap, but positive HPV (one genotyped 18). Colpo CIN 1. Could not get algorithm for plan